BioNTech SE BNTX Income Statement (2018-2026)

NASDAQ BNTX
$87.21 -0.30 (-0.34%)
At close: Nov 10, 2026 · 4:00 PM EST
Reported Financials

BioNTech SE Quarterly Income Statement

Periods 33 quarters
Latest Sep 2026

BioNTech SE reported revenue of $1483.13M and net income of $212.25M for the quarter ended Sep 2026, down 16.5% year over year. This income statement covers 33 quarters of results from Sep 2018 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Income StatementIncome Statement Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Revenue & cost
Revenue
6,329.02M7,154.45M3,410.85M3,489.84M4,364.92M1,370.66M182.61M974.62M1,591.32M203.80M138.60M1,367.06M1,271.63M192.28M295.22M1,775.68M1,056.25M138.27M122.75M1,483.13M
Cost of RevenueCost of Rev
667.16M1,452.42M815.87M759.03M187.22M103.04M177.39M176.13M192.70M64.20M64.40M196.47M260.20M88.15M86.48M173.37M387.98M83.59M112.75M118.84M
Gross Profit
5,661.86M5,702.04M2,594.98M2,730.81M4,177.71M1,267.62M5.23M798.48M1,398.61M139.60M74.20M1,170.59M1,011.43M104.14M208.73M1,602.31M668.28M54.67M10.00M1,364.29M
Operating items
Research & DevelopmentR&D
310.59M320.76M426.40M344.63M520.12M358.50M406.60M542.01M621.68M551.33M629.55M604.35M653.77M552.87M576.28M660.28M588.31M652.11M640.46M860.63M
Selling, General & AdministrativeSG&A
149.75M101.91M138.72M142.17M122.33M120.00M130.45M151.42M133.74M127.10M184.04M145.40M118.40M112.45M133.23M141.69M196.26M143.88M183.30M155.54M
Other Operating ExpensesOther Opex
-76.76M-80.36M-256.84M-287.46M-386.88M-134.92M-83.96M-40.06M-61.97M-25.96M-313.16M-451.26M-97.88M-51.02M-132.67M-852.83M-242.12M-54.79M-288.38M-188.21M
Operating ExpensesOpex
460.33M422.67M565.11M486.79M642.45M478.50M537.06M693.43M755.42M678.43M813.59M749.75M772.17M665.32M709.51M801.97M784.57M795.99M823.77M1,016.17M
Operating IncomeOp. Inc
5,376.32M5,334.13M2,357.77M2,407.25M3,359.57M702.39M-613.39M79.58M566.16M-551.00M-1,040.49M11.53M158.79M-561.81M-567.22M-54.83M-375.75M-793.18M-1,102.04M143.80M
Non-operating items
Non Operating Interest Expenses
-2.40M-7.52M-6.19M-4.34M-162.32M-31.13M-1.42M-2.18M-27.11M-5.11M-7.86M-8.79M-13.46M-35.66M-7.92M-29.46M-4.89M-13.11M-9.18M-9.55M
Interest & Investment IncomeInt & Inv Inc
18.65M305.39M123.25M61.40M39.59M88.34M165.95M170.15M174.52M195.65M180.59M171.54M176.53M128.96M119.31M113.16M115.94M141.19M113.10M121.14M
Other Non Operating IncomeOther Non Op Inc.
188.89M-2.97M-27.35M111.38M
Net income details
EBIT
5,376.32M5,334.13M2,357.77M2,407.25M3,359.57M702.39M-613.39M79.58M566.16M-551.00M-1,040.49M11.53M158.79M-561.81M-567.22M-54.83M-375.75M-793.18M-1,102.04M143.80M
EBT
5,392.56M5,632.00M2,474.82M2,464.32M3,236.84M759.60M-448.85M247.55M713.56M-360.45M-867.76M174.29M321.86M-468.51M-455.84M28.88M-264.70M-665.10M-998.12M255.39M
Tax ProvisionsTaxes
-1,770.52M-1,480.70M-690.71M-664.65M-912.00M-220.57M241.52M-72.72M-220.89M18.14M-2.15M43.27M-44.56M31.14M18.22M-62.43M-90.33M42.38M44.05M-43.14M
Income After Tax
7,163.09M7,112.70M3,165.53M3,128.98M4,148.84M980.18M-690.38M320.26M934.45M-378.60M-865.60M131.02M366.42M-499.65M-474.06M91.30M-174.37M-707.48M-1,042.17M298.54M
Equity Income
Income from Continuing OperationsIncome (Continuing)
7,163.09M7,112.70M3,165.53M3,128.98M4,148.84M980.18M-690.38M320.26M934.45M-378.60M-865.60M131.02M366.42M-499.65M-474.06M91.30M-174.37M-707.48M-1,042.17M298.54M
Consolidated Net IncomeConsol Net Inc.
3,622.04M4,151.30M1,784.12M1,799.67M2,324.84M539.03M-207.33M174.83M492.67M-342.31M-869.91M217.56M277.30M-499.65M-474.06M-33.55M-355.03M-707.48M-1,042.17M212.25M
Net Income Attributable to Noncontrolling InterestsNCI Net Income
Income towards Parent CompanyParent Net Inc
3,622.04M4,151.30M1,784.12M1,799.67M2,324.84M539.03M-207.33M174.83M492.67M-342.31M-869.91M217.56M277.30M-437.37M-437.62M-33.55M-355.03M-622.72M-954.07M212.25M
Net Income towards Common StockholdersNet Income
3,622.04M4,151.30M1,784.12M1,799.67M2,324.84M539.03M-207.33M174.83M492.67M-342.31M-869.91M217.56M277.30M-453.15M-437.62M-33.55M-355.03M-622.72M-954.07M212.25M
Additional items
EPS (Basic)
14.8417.017.317.389.562.22-0.850.722.05-1.42-3.620.901.15-1.88-1.82-0.14-1.47-2.58-3.950.88
EPS (Diluted)
13.9515.986.876.939.312.16-0.830.702.03-1.41-3.580.901.15-1.88-1.82-0.14-1.47-2.58-3.950.88
Shares Outstanding
244.00M244.00M244.00M244.00M243.30M243.30M243.30M243.30M240.60M240.60M240.60M240.60M240.40M240.40M240.40M240.40M241.70M241.70M241.70M241.70M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
259.70M259.70M259.70M259.70M249.80M249.80M249.80M249.80M242.70M242.70M242.70M242.70M240.40M240.40M240.40M240.40M241.70M241.70M241.70M241.70M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
246.81M240.99M237.73M239.97M252.88M
EBITDA
5,406.06M5,365.11M2,393.19M2,441.03M3,389.16M736.10M-578.65M124.53M650.94M-509.40M-986.75M60.29M335.54M-516.79M-509.50M90.37M-183.92M-651.17M-792.73M526.09M
Interest ExpensesInt Expense
-2.40M-7.52M-6.19M-4.34M-162.32M-31.13M-1.42M-2.18M-27.11M-5.11M-7.86M-8.79M-13.46M-35.66M-7.92M-29.46M-4.89M-13.11M-9.18M-9.55M
Tax Rate
24.83%

BioNTech SE Income Statement API

Pull BioNTech SE's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=BNTX&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY